The Role of Dysfunctional HDL in Sepsis
NCT02934997 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88
Last updated 2020-02-24
Summary
To determine the role of dysfunctional high density lipoprotein (Dys-HDL) in predicting or mediating progression to chronic critical illness or morbid long-term outcomes in patients being treated for community-acquired or hospital-acquired sepsis.
Conditions
- Sepsis
- Septic Shock
Interventions
- OTHER
-
Observational study
Sponsors & Collaborators
-
National Institute of General Medical Sciences (NIGMS)
collaborator NIH -
University of Florida
lead OTHER
Principal Investigators
-
Faheem Guirgis, MD · University of Florida
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-01
- Primary Completion
- 2019-05-03
- Completion
- 2019-05-03
More Related Trials
-
Prognostic Interest of Leucocyte Immunophenotyping During the Acute Phase of Sepsis
NCT01995448 ·Status: COMPLETED
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
Septic Encephalopathy and Late Cognitive Dysfunction
NCT00772096 ·Status: COMPLETED ·Phase: PHASE4
-
A Prospective Observational Study of Sepsis
NCT05309889 ·Status: UNKNOWN
-
Correlation Between PTP1B Expression and Organ Failure During Sepsis
NCT02295514 ·Status: COMPLETED ·Phase: NA
-
Ultrasound Diaphragmatic Thickening to Monitor Its Dysfunction in Patients With Sepsis
NCT02474797 ·Status: COMPLETED ·Phase: NA
-
Sepsis in the ICU-II
NCT04695119 ·Status: ACTIVE_NOT_RECRUITING
-
Impact of Low Dose Unfractionated Heparin Treatment on Inflammation in Sepsis
NCT02135770 ·Status: COMPLETED ·Phase: PHASE3
-
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis
NCT01535534 ·Status: UNKNOWN
-
Novel Sepsis Sub-phenotypes Based on Trajectories of Vital Signs
NCT05826223 ·Status: COMPLETED
-
De-escalation of Empirical Antimicrobial Therapy Study in Severe Sepsis
NCT01626612 ·Status: COMPLETED ·Phase: PHASE3
-
Mitochondrial Function of Immune Cells in Sepsis
NCT01600989 ·Status: COMPLETED
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Evolution of Muscle Function, Breathlessness and Quality of Life Following Intra or Extra-Abdominal Sepsis in ICU Patients
NCT06010186 ·Status: RECRUITING ·Phase: NA
-
Serial Body Composition Change for Risk Prediction and Nutritional Guide in Treating Patients With Sepsis
NCT04989569 ·Status: COMPLETED ·Phase: NA
-
Adiposity and Immunometabolism in Sepsis
NCT06307509 ·Status: NOT_YET_RECRUITING
-
Dissecting How Peripheral Lymphocytes Are Lost During Sepsis
NCT03289312 ·Status: UNKNOWN
-
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
NCT02803346 ·Status: UNKNOWN
-
Pro-inflammatory Role of Blood Platelets in Critically Ill Patients With Septic Shock.
NCT04080453 ·Status: COMPLETED
-
Mitochondrial Function in Septic Patients
NCT03748537 ·Status: COMPLETED ·Phase: NA
-
Endothelium in Severe Sepsis
NCT00793442 ·Status: COMPLETED
-
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
NCT05229328 ·Status: UNKNOWN
-
The Effects of Interferon-gamma on Sepsis-induced Immunoparalysis
NCT01649921 ·Status: COMPLETED ·Phase: PHASE3
-
Alterations of Immunologic Mediators During Severe Sepsis
NCT00484146 ·Status: TERMINATED